Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00958971
What this trial is testing

Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals 43
Testing effectiveness (Phase 2)Study completedNCT00633464
What this trial is testing

Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer

Who this might be right for
Triple Negative Locally Advanced Non-resectable Breast CancerMetastatic Breast Cancer
R-Pharm 79
Very early researchEnded earlyNCT04712721
What this trial is testing

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

Who this might be right for
Glioblastoma MultiformeBrain NeoplasmsGastroesophageal Adenocarcinoma+1 more
Novartis Pharmaceuticals 14
Not applicableWithdrawnNCT03974204
What this trial is testing

Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.

Who this might be right for
Breast CancerLeptomeningeal Metastasis
Centre Oscar Lambret
Not applicableLooking for participantsNCT07487844
What this trial is testing

Pulsed Electric Field Ablation for Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerBreast Cancer
University of California, San Francisco 20
Testing effectiveness (Phase 2)Looking for participantsNCT07108309
What this trial is testing

BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Biocad 124
Testing effectiveness (Phase 2)Ended earlyNCT01531764
What this trial is testing

BIBW 2992 (Afatinib) and Vinorelbine

Who this might be right for
Carcinoma Breast Stage IV
University of Magdeburg 2
Not applicableLooking for participantsNCT07415564
What this trial is testing

Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers

Who this might be right for
Cancer MetastaticSymptoms and SignsQuality of Life
University of Arizona 200
Large-scale testing (Phase 3)Study completedNCT00002544
What this trial is testing

Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Arbeitsgemeinschaft fur Internistische Onkologie 300
Not applicableStudy completedNCT06975371
What this trial is testing

Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6i

Who this might be right for
Advanced/Metastatic HER2-negative Breast Cancer
Daiichi Sankyo 1,415
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05232006
What this trial is testing

PARP-inhibitor on Advanced Metastatic Breast Cancer in Germline PALB2 Mutations Carriers

Who this might be right for
Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers
Assistance Publique - Hôpitaux de Paris 12
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Large-scale testing (Phase 3)Study completedNCT01108016
What this trial is testing

Expanding Rural Access: Distance Delivery of Support Groups (Main Study)

Who this might be right for
DepressionBreast CancerStress+3 more
Stanford University 100
Testing effectiveness (Phase 2)WithdrawnNCT05191004
What this trial is testing

Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC

Who this might be right for
Advanced Breast CancerMetastatic Breast CancerBreast Cancer+5 more
Nuvation Bio Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT05732051
What this trial is testing

Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Breast CancerMetastatic Breast CancerCancer Therapy-Related Cardiac Dysfunction+2 more
University Hospital, Akershus 60
Testing effectiveness (Phase 2)Study completedNCT01086605
What this trial is testing

Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 46
Not applicableActive Not RecruitingNCT03281902
What this trial is testing

Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

Who this might be right for
Advanced Breast CarcinomaLocally Advanced Breast CarcinomaMetastatic Breast Carcinoma+6 more
Mayo Clinic 68
Large-scale testing (Phase 3)UnknownNCT04736186
What this trial is testing

Prevention and Treatment of Pyrrolitinib-associated Diarrhea

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 470
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Testing effectiveness (Phase 2)Study completedNCT00243503
What this trial is testing

Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 60
Next Page